Meta-anlaysis of Internet-based Behavior Therapy for Tic Disorder.

IF 2.4 4区 医学 Q3 NEUROSCIENCES
Clinical Psychopharmacology and Neuroscience Pub Date : 2025-08-31 Epub Date: 2025-05-23 DOI:10.9758/cpn.25.1294
Yeong-Dae Jo, Dae-Jin Kim, Kyu-Sic Hwang, Chan-Gyu Jung, Su-Woo Lee, Dong-Ho Lee, Su-In Jung, Sung-Hoon Yoon, Sang-Yeol Lee, Chan-Mo Yang
{"title":"Meta-anlaysis of Internet-based Behavior Therapy for Tic Disorder.","authors":"Yeong-Dae Jo, Dae-Jin Kim, Kyu-Sic Hwang, Chan-Gyu Jung, Su-Woo Lee, Dong-Ho Lee, Su-In Jung, Sung-Hoon Yoon, Sang-Yeol Lee, Chan-Mo Yang","doi":"10.9758/cpn.25.1294","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Tourette syndrome and chronic tic disorders are neurodevelopmental disorders characterized by involuntary motor and vocal tics, often beginning in childhood and causing significant distress. While medication and behavioral therapies are established treatments, chronic use of medication can cause side effects, and behavioral therapy faces limited provider availability and geographic barriers. Internet-based behavioral interventions are emerging as alternatives to improve treatment accessibility.</p><p><strong>Methods: </strong>We performed a meta-analysis of five randomized controlled trials examining online delivery of comprehensive behavioral interventions for tics/habit reversal training or exposure and response prevention for tic disorders. Primary outcomes included Yale Global Tic Severity Scale scores and treatment response rate. A fixed-effect model was used, with heterogeneity and subgroup analyses to assess consistency.</p><p><strong>Results: </strong>The overall Hedges' g was -0.26 (95% CI: -0.42 to -0.10, <i>p</i> = 0.0019), indicating a small but significant effect of online interventions. Treatment response odds ratio was 2.34 (95% CI: 1.55-3.52, <i>p</i> < 0.001), with no significant subgroup differences by control condtion, age, intervention, or delivery method.</p><p><strong>Conclusion: </strong>In this meta-analysis, internet-based behavior therapy demonstrated modest yet statistically significant reductions in tic symptoms, marginally lower than those achieved with in-person. Nevertheless, their cost-effectiveness and potential to broaden treatment accessibility underscore the necessity for large-scale, methodologically rigorous trials that explore long-term outcomes, developmental considerations, and comorbidities. Our findings support the clinical utility and feasibility of internet-based behavior therapy for tic disorders. This approach may broaden treatment access for underserved communities and potentially improve patients' quality of life in the digital healthcare era.</p>","PeriodicalId":10420,"journal":{"name":"Clinical Psychopharmacology and Neuroscience","volume":"23 3","pages":"453-466"},"PeriodicalIF":2.4000,"publicationDate":"2025-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12264671/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Psychopharmacology and Neuroscience","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.9758/cpn.25.1294","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/23 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Tourette syndrome and chronic tic disorders are neurodevelopmental disorders characterized by involuntary motor and vocal tics, often beginning in childhood and causing significant distress. While medication and behavioral therapies are established treatments, chronic use of medication can cause side effects, and behavioral therapy faces limited provider availability and geographic barriers. Internet-based behavioral interventions are emerging as alternatives to improve treatment accessibility.

Methods: We performed a meta-analysis of five randomized controlled trials examining online delivery of comprehensive behavioral interventions for tics/habit reversal training or exposure and response prevention for tic disorders. Primary outcomes included Yale Global Tic Severity Scale scores and treatment response rate. A fixed-effect model was used, with heterogeneity and subgroup analyses to assess consistency.

Results: The overall Hedges' g was -0.26 (95% CI: -0.42 to -0.10, p = 0.0019), indicating a small but significant effect of online interventions. Treatment response odds ratio was 2.34 (95% CI: 1.55-3.52, p < 0.001), with no significant subgroup differences by control condtion, age, intervention, or delivery method.

Conclusion: In this meta-analysis, internet-based behavior therapy demonstrated modest yet statistically significant reductions in tic symptoms, marginally lower than those achieved with in-person. Nevertheless, their cost-effectiveness and potential to broaden treatment accessibility underscore the necessity for large-scale, methodologically rigorous trials that explore long-term outcomes, developmental considerations, and comorbidities. Our findings support the clinical utility and feasibility of internet-based behavior therapy for tic disorders. This approach may broaden treatment access for underserved communities and potentially improve patients' quality of life in the digital healthcare era.

网络行为治疗抽动障碍的meta分析。
图雷特综合征和慢性抽动障碍是神经发育障碍,其特征是不自主的运动和声音抽动,通常始于儿童时期并引起严重的痛苦。虽然药物和行为疗法是既定的治疗方法,但长期使用药物可能会产生副作用,行为疗法面临提供者有限和地理障碍。基于互联网的行为干预正在成为改善治疗可及性的替代方案。方法:我们对五项随机对照试验进行了荟萃分析,这些试验检查了抽动/习惯逆转训练或抽动障碍暴露和反应预防的综合行为干预在线交付。主要结局包括耶鲁全球抽动严重程度量表评分和治疗反应率。采用固定效应模型,通过异质性和亚组分析来评估一致性。结果:总体对冲系数g为-0.26 (95% CI: -0.42至-0.10,p = 0.0019),表明在线干预的影响虽小但显著。治疗反应优势比为2.34 (95% CI: 1.55-3.52, p < 0.001),对照条件、年龄、干预或递送方式的亚组差异无统计学意义。结论:在这项荟萃分析中,基于互联网的行为疗法显示出适度但统计学上显著的抽动症状减少,略低于面对面治疗的效果。然而,它们的成本效益和扩大治疗可及性的潜力强调了进行大规模、方法学上严格的试验的必要性,这些试验探讨了长期结果、发展考虑和合并症。我们的研究结果支持基于网络的行为治疗抽动障碍的临床应用和可行性。这种方法可以扩大服务不足社区的治疗机会,并有可能改善数字医疗保健时代患者的生活质量。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical Psychopharmacology and Neuroscience
Clinical Psychopharmacology and Neuroscience NEUROSCIENCESPHARMACOLOGY & PHARMACY-PHARMACOLOGY & PHARMACY
CiteScore
4.70
自引率
12.50%
发文量
81
期刊介绍: Clinical Psychopharmacology and Neuroscience (Clin Psychopharmacol Neurosci) launched in 2003, is the official journal of The Korean College of Neuropsychopharmacology (KCNP), and the associate journal for Asian College of Neuropsychopharmacology (AsCNP). This journal aims to publish evidence-based, scientifically written articles related to clinical and preclinical studies in the field of psychopharmacology and neuroscience. This journal intends to foster and encourage communications between psychiatrist, neuroscientist and all related experts in Asia as well as worldwide. It is published four times a year at the last day of February, May, August, and November.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信